|
Showing 1 - 12 of
12 matches in All Departments
Here is a comprehensive overview of the drugs that act on the
central and peripheral nervous systems. This volume thoroughly
describes the diseases associated with the nervous system and the
drugs used for their treatment while also looking at the current
status of these drugs and their future potential and challenges.
Divided into three sections, the book first focuses on the drugs
that affect the functions of the autonomic nervous system to
produce therapeutic effects. These drugs may act presynaptically by
manipulating the genesis, storage, and secretion, and by blocking
the action of neurotransmitters. Some drugs may trigger or impede
postsynaptic receptors. Section 2 focuses on drugs that affect the
central nervous system, including antianxiety drugs, sedative and
hypnotic drugs, antidepressant drugs, antipsychotic drugs,
antiepileptic drugs, and many more. It covers the pharmacological
management of various diseases, including Alzheimer's, Parkinson's,
Huntington's, and others. The last section offers explanations of
neurochemical interactions with the aim to develop drugs that have
beneficial effects on neurochemical imbalances. This section
demonstrates models to assess the transport of drugs across the
blood-brain barrier and nanomedicine to treat brain disorders. This
rich compilation provides thorough and extensive research updates
on the important advances in neuropharmacological drugs and drug
therapy from experienced and eminent academicians, researchers, and
scientists from throughout the world.
Most existing texts covering topics in Islamic finance discuss the
potential of Islamic banking; very few talk about other forms of
financing and the investment activities of Islamic firms from the
standpoint of owners and managers. This book fills this gap by
looking at the traditional as well as non-traditional financing and
investment activities of shariah-compliant companies. The chapters
in this edited text offer a full range of topics on corporate
finance for Islamic firms, including global comparisons of shariah
screening, dividend policy and capital structure of Islamic firms,
details of global Islamic equity markets, trends and performance of
sukuk markets, and a brief account of derivative securities that
can be used in Islamic finance. This is a useful reference for
anyone who wishes to learn more about the performance of
shariah-compliant companies vis-a-vis conventional firms. The book
includes both technical and non-technical information that would be
suitable for classroom teaching as well as a reference for
postgraduate research students.
Demonstrating high quality theoretical and empirical findings in
the areas of Islamic finance, banking, entrepreneurship, insurance,
capital market, Islamic leadership, and Halal marketing, this new
work includes topics on consumer perception, services orientation,
new product development, risk management, industry readiness for
better customer satisfaction, and policy issues coupling strategy
and best practices. Of interest to both academics and practitioners
who assist in making Shariah-centric strategies, this work is
particularly important as Asia holds a major percentage of Islamic
assets in South Asia, Southeast Asia, and the Middle East, with new
opportunities opening in Central Asia.
Here is a comprehensive overview of the drugs that act on the
central and peripheral nervous systems. This volume thoroughly
describes the diseases associated with the nervous system and the
drugs used for their treatment while also looking at the current
status of these drugs and their future potential and challenges.
Divided into three sections, the book first focuses on the drugs
that affect the functions of the autonomic nervous system to
produce therapeutic effects. These drugs may act presynaptically by
manipulating the genesis, storage, and secretion, and by blocking
the action of neurotransmitters. Some drugs may trigger or impede
postsynaptic receptors. Section 2 focuses on drugs that affect the
central nervous system, including antianxiety drugs, sedative and
hypnotic drugs, antidepressant drugs, antipsychotic drugs,
antiepileptic drugs, and many more. It covers the pharmacological
management of various diseases, including Alzheimer's, Parkinson's,
Huntington's, and others. The last section offers explanations of
neurochemical interactions with the aim to develop drugs that have
beneficial effects on neurochemical imbalances. This section
demonstrates models to assess the transport of drugs across the
blood-brain barrier and nanomedicine to treat brain disorders. This
rich compilation provides thorough and extensive research updates
on the important advances in neuropharmacological drugs and drug
therapy from experienced and eminent academicians, researchers, and
scientists from throughout the world.
Islamic finance has emerged as an alternative to century-old
conventional financial instruments to cater to cater to the needs
of Muslims as well as non-Muslims. The industry has seen
significant growth over the last two decades and has been facing
omnidirectional challenges with respect to regulation, competition,
and compatibility. These challenges have presented worthy debate on
the principles, practices, and performance in Islamic finance
globally. In this issue, we have presented issues relevant to the
most recent debate on the performance, practices, and principles of
the Islamic finance industry as a whole, covering eleven distinct
issues. Authors have contributed to the existing body of knowledge
on risk management in Islamic banks, diversification in Islamic
equity markets, performance and acceptance of Islamic microcredit
and Islamic banking services, long-term corporate finance using
sukuk, and the social development agenda via the development of
financial intuitions, SME financing, and financial inclusion.
Selected topics cover the principles in relevant areas, focus on
recent practices, and highlight performance on certain influential
areas. The issue is aimed at academicians, researchers, and
policymakers who are working in the Islamic finance industry and
who would like to explore more.
Most existing texts covering topics in Islamic finance discuss the
potential of Islamic banking; very few talk about other forms of
financing and the investment activities of Islamic firms from the
standpoint of owners and managers. This book fills this gap by
looking at the traditional as well as non-traditional financing and
investment activities of shariah-compliant companies. The chapters
in this edited text offer a full range of topics on corporate
finance for Islamic firms, including global comparisons of shariah
screening, dividend policy and capital structure of Islamic firms,
details of global Islamic equity markets, trends and performance of
sukuk markets, and a brief account of derivative securities that
can be used in Islamic finance. This is a useful reference for
anyone who wishes to learn more about the performance of
shariah-compliant companies vis-a-vis conventional firms. The book
includes both technical and non-technical information that would be
suitable for classroom teaching as well as a reference for
postgraduate research students.
This book explores several challenges facing FinTech in Islamic
financial institutions. Firstly, large banks and financial
institutions in countries with updated and innovative technological
channels will earn the technology arbitrage from FinTech. This
'size' puzzle may create a challenge for Islamic financial
institutions that are of smaller size and from technologically
less-developed countries. Secondly, while access to FinTech is
getting broader day by day, usage of FinTech is still limited due
to personal and governance-related limitations. Moreover, the level
of awareness of the emerging FinTech services (i.e., bitcoin,
blockchain, etc.) remains extremely poor even among the residents
of technologically-advanced countries. Thirdly, use of FinTech by
Islamic financial institutions is limited to Islamic banking, to
users from developed countries, among young customers, and for a
limited number of traditional banking services such as the deposits
and payment services. Also, banks hope to use FinTech to increase
the size of a new breed of technology-savvy depositors and loan
customers to achieve economies of scale, which may help stabilize
the banking sector. Automation in Islamic banks and the
participation of Islamic financial institutions in blockchain and
bitcoin domains require extensive research from Shariah-compliance
as well as market and consumer-related grounds. With all the
opportunities and challenges of FinTech-promoting inclusion, easier
loan monitoring, and risk of Shariah non-compliance-this book
explores the implications for Islamic financial institutions and
will be of interest to scholars, researchers, and students of
Islamic finance and financial technology.
Muslim consumers represent an untapped and viable market segment,
but to date there has been very little research on catering to
their needs or running and managing Islamic businesses. Innovations
in Islamic business, interest in the use of Sukuk (Islamic bonds)
to finance major projects, pressures on Islamic banks to reduce the
financing gap in society, and the need to understand Muslim
consumers, require a deeper grasp of the issues and opportunities
involved, which are quite unique. In similar vein, acquiring
expertise on topics specific to Shari'ah-compliant businesses
requires a thorough knowledge of matters ranging from financing to
branding and, in a broader sense, creating an entrepreneurial
framework suitable to the market. This book fills this gap by
presenting high-quality and original case studies on Islamic
finance, marketing and management from around the world. Equally
valuable in business school classrooms and for c-suite strategists,
it will help readers shape business strategies to tap into a
billion-strong market.
An field experiment was carried out under the Department of Plant
Pathology, Hajee Mohammad Danesh Science & Technology
University, Dinajpur during the period of July 2009 to December
2009 to find out the fungicidal management of sheath blight of
rice. Three fungicides viz. Bavistin 50 WP, Tilt 250 EC and
Folicour EW 250 were sprayed against R. solani causing sheath
blight on three aman rice varieties viz. Hybrid Hera, BRRI Dhan-49
and BR-11.Control plot was sprayed with plain water. The
experiments were laid out in two factors Randomized Complete Block
Design (RCBD) with three replications. From the present findings it
may be concluded that Folicour EW 250 was a promising fungicide for
lowering sheath blight incidence and BR-11 was the best variety
among the three rice varieties in aspect of yield.
|
You may like...
Personal Shopper
Kristen Stewart, Nora von Waldstätten, …
DVD
R86
Discovery Miles 860
|